全文获取类型
收费全文 | 168135篇 |
免费 | 6519篇 |
国内免费 | 404篇 |
专业分类
耳鼻咽喉 | 2211篇 |
儿科学 | 4885篇 |
妇产科学 | 3993篇 |
基础医学 | 24248篇 |
口腔科学 | 5520篇 |
临床医学 | 9698篇 |
内科学 | 37221篇 |
皮肤病学 | 4744篇 |
神经病学 | 13372篇 |
特种医学 | 4297篇 |
外国民族医学 | 1篇 |
外科学 | 19275篇 |
综合类 | 829篇 |
一般理论 | 24篇 |
预防医学 | 19941篇 |
眼科学 | 4384篇 |
药学 | 13056篇 |
中国医学 | 679篇 |
肿瘤学 | 6680篇 |
出版年
2023年 | 836篇 |
2022年 | 694篇 |
2021年 | 2687篇 |
2020年 | 1517篇 |
2019年 | 3019篇 |
2018年 | 4986篇 |
2017年 | 3105篇 |
2016年 | 3103篇 |
2015年 | 3452篇 |
2014年 | 3911篇 |
2013年 | 5972篇 |
2012年 | 10154篇 |
2011年 | 10721篇 |
2010年 | 5371篇 |
2009年 | 4011篇 |
2008年 | 8758篇 |
2007年 | 9415篇 |
2006年 | 9037篇 |
2005年 | 8617篇 |
2004年 | 7996篇 |
2003年 | 7510篇 |
2002年 | 7131篇 |
2001年 | 4951篇 |
2000年 | 5513篇 |
1999年 | 4232篇 |
1998年 | 826篇 |
1992年 | 2277篇 |
1991年 | 2031篇 |
1990年 | 2027篇 |
1989年 | 1754篇 |
1988年 | 1675篇 |
1987年 | 1560篇 |
1986年 | 1599篇 |
1985年 | 1492篇 |
1984年 | 1094篇 |
1983年 | 923篇 |
1979年 | 1230篇 |
1978年 | 836篇 |
1977年 | 815篇 |
1976年 | 779篇 |
1975年 | 912篇 |
1974年 | 1129篇 |
1973年 | 1167篇 |
1972年 | 1135篇 |
1971年 | 1099篇 |
1970年 | 1034篇 |
1969年 | 1102篇 |
1968年 | 1122篇 |
1967年 | 983篇 |
1966年 | 889篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Ambrus Géza Gergely Amado Catarina Krohn Laura Kovács Gyula 《Brain structure & function》2019,224(1):149-157
Brain Structure and Function - Accumulating evidence suggests that besides its function in early facial feature processing, the role of the right occipital face area (rOFA) extends to higher level,... 相似文献
52.
J.-H. Ko C.-I. Kang P. Cornejo-Juárez K.-M. Yeh C.-H. Wang S.Y. Cho M.G. Gözel S.-H. Kim P.-R. Hsueh N. Sekiya Y. Matsumura D.-G. Lee S.-Y. Cho S. Shiratori Y.-J. Kim D.R. Chung K.R. Peck 《Clinical microbiology and infection》2019,21(5):546-554
BackgroundFluoroquinolones are a popular alternative to trimethoprim-sulfamethoxazole for Stenotrophomonas maltophilia infections.ObjectivesTo compare the effects of fluoroquinolones and trimethoprim-sulfamethoxazole on mortality of S. maltophilia infections.Data sourcesPubMed and EMBASE.Study eligibility criteriaClinical studies reporting mortality outcomes of S. maltophilia infections.ParticipantsPatients with clinical infections caused by S. maltophilia.InterventionsFluoroquinolone monotherapy in comparison with trimethoprim-sulfamethoxazole monotherapy.MethodsSystematic review with meta-analysis technique.ResultsSeven retrospective cohort and seven case–control studies were included. Three cohort studies were designed to compare the two drugs, whereas others had other purposes. A total of 663 patients were identified, 332 of which were treated with trimethoprim-sulfamethoxazole (50.1%) and 331 with fluoroquinolones (49.9%). Three cohort studies were designed to compare the effect of the two drugs, whereas the others had other purposes. Levofloxacin was most frequently used among fluoroquinolones (187/331, 56.5%), followed by ciprofloxacin (114/331, 34.4%). The overall mortality rate was 29.6%. Using pooled ORs for the mortality of each study, fluoroquinolone treatment (OR 0.62, 95% CI 0.39–0.99) was associated with survival benefit over trimethoprim-sulfamethoxazole treatment, with low heterogeneity (I2 = 18%). Specific fluoroquinolones such as ciprofloxacin (OR 0.44, 95% CI 0.17–1.12) and levofloxacin (OR 0.78, 95% CI 0.48–1.26) did not show a significant difference in comparison with trimethoprim-sulfamethoxazole. In the sub-group analyses of adult and bacteraemic patients, significant differences in mortality were not observed between fluoroquinolones and trimethoprim-sulfamethoxazole.ConclusionsBased on a meta-analysis of non-randomized studies, fluoroquinolones demonstrated comparable effects on mortality of S. maltophilia infection to trimethoprim-sulfamethoxazole, supporting the use of fluoroquinolones in clinical S. maltophilia infections. Although the pooled analysis of overall studies favoured fluoroquinolones over trimethoprim-sulfamethoxazole, the studies included were observational, and sub-group analyses of certain fluoroquinolone agents did not show statistical differences with trimethoprim-sulfamethoxazole. Randomized clinical studies are needed to address these issues. 相似文献
53.
Greve Christian Hortobágyi Tibor Bongers Raoul M. 《European journal of applied physiology》2019,119(2):419-428
European Journal of Applied Physiology - We examined the possibility that old adults use flexibility in joint coordination as a compensatory mechanism for the age-related decline in muscle strength... 相似文献
54.
Camila Aparecida de Carvalho Thiago Fidelis Ferrão Flávia Regina Novais de Freitas Heitor Franco de Andrade Júnior 《Immunology》2019,158(4):314-321
Visceral leishmaniasis (VL) is epidemic in Brazil with an increasing incidence of human cases and canine reservoirs, with host hypergammaglobulinemia. Conventional enzyme-linked immunosorbent assay (cELISA) based on several parasitic antigens is the main method for diagnosis and indication of treatment. Dissociative ELISA (dELISA) uses acidic treatment to free immunoglobulin G (IgG) from immune complexes, and its use revealed a significant positive fraction of suspected cases with negative serology. Looking for small molecules or haptens that block IgG antibodies, we purified by molecular exclusion chromatography, 1000–3000 MW molecules from promastigote soluble extract, mostly oligosaccharides comprising 6–13 sugar residues using MALDI-TOF analysis. Glycan-BSA complex (GBC) was constructed by conjugating promastigote glycans to BSA molecules, allowing their use in the solid support in cELISA or dELISA. Sera from experimentally infected hamsters showed higher levels of blocked monomeric IgG during infection, mostly against GBC, which was also present in lower concentrations in the promastigote soluble extract dELISA. Those data show that most of the specific monomeric IgG in serum are blocked by haptens composed by glycans produced by the parasite, better detected in the high dilution of sera in the dELISA assays. dELISA is a useful technique for detecting blocked monomeric antibodies that could have difficult clearance from blood, which could result in hypergammaglobulinemia. 相似文献
55.
56.
Paulo Roberto P. Urbano Luiz H. da Silva Nali Renato dos R Oliveira MS Laura M. Sumita Maria Cristina D. da Silva Fink Lígia C Pierrotti MD MS Camila da Silva Bicalho Elias David-Neto MD Cláudio S. Pannuti MD Camila M Romano 《Journal of medical virology》2019,91(6):1136-1141
BK virus is the causative agent of polyomavirus-associated nephropathy, a major cause of kidney transplant failure affecting 1%-10% of recipients. Previous studies that investigated the viral source on the kidney recipient pointed that the donor is implicated in the origin of human polyomavirus BK (BKPyV) infection in recipients, but giving the low genetic variability of BKPyV this subject is still controversial. The aim of this study was to determine if BKPyV replicating in kidney recipients after transplantation is always originated from the donor. Urine and blood samples from 68 pairs of living donors and kidney recipients who underwent renal transplantation from August 2010-September 2011 were screened for BKPyV by real time polymerase chain reaction. Only three recipients presented viremia. When both donors and recipients were BKPyV positive, a larger fragment of VP1 region was obtained and sequenced to determine the level of similarity between them. A phylogenetic tree was built for the 12 pairs of sequences obtained from urine and high level of similarity among all sequences was observed, indicating that homology inferences for donor and recipient viruses must be cautiously interpreted. However, a close inspection on the donor-recipient pairs sequences revealed that 3 of 12 pairs presented considerably different viruses and 4 of 12 presented mixed infection, indicating that the source of BKPyV infection is not exclusively derived from the donor. We report that about 60% of the renal recipients shed BKPyV genetically distinct from the donor, confronting the accepted concept that the donor is the main source of recipients’ infection. 相似文献
57.
Alberto Talaya Estela Giménez José Luis Piñana Eliseo Albert Juan Carlos Hernández-Boluda Ariadna Pérez Ignacio Torres Carlos Solano David Navarro 《Journal of medical virology》2019,91(6):1128-1135
It has been reported that low-plasma cytomegalovirus (CMV) DNA loads are associated with an increased risk of overall mortality in allogeneic hematopoietic stem cell transplantation (allo-HSCT). Utilizing a conservative strategy for initiation of preemptive antiviral therapy (>1500 IU/mL), we characterized the virological features of spontaneously-resolving episodes of CMV DNAemia and assessed their impact on mortality through the first year after transplantation. We reviewed the CMV DNA polymerase chain reaction results and clinical charts of 230 consecutive adult patients who underwent T-cell replete allo-HSCT at our center. A total of 280 episodes of CMV DNAemia were registered in 164 patients, of which 144 episodes cleared spontaneously. Clearance of CMV DNAemia was significantly delayed in initial and recurrent self-resolving episodes featuring CMV DNA peak loads > 250 IU/mL compared with those displaying lower values. All-cause mortality in patients with self-resolving episodes of CMV DNAemia was comparable (P = 0.7) to that in patients with no CMV DNAemia and was not related to the CMV DNA peak load (≥250 IU/mL vs <250 IU/mL) (P = 0.6). In summary, in our setting, the magnitude of the CMV DNA peak load reached during self-resolving episodes of CMV DNAemia correlated directly with duration of episodes, but had no apparent impact on all-cause mortality taking patients with no documented CMV DNAemia as a reference. 相似文献
58.
59.
Daniela P. Lage Amanda S. Machado Fernanda F. Ramos Patrícia C. Silveira Daniel S. Dias Patrícia A.F. Ribeiro Grasiele S.V. Tavares Lourena E. Costa Thaís T.O. Santos Bethina T. Steiner Mírian I. Fagundes Miguel A. Chávez-Fumagalli Sandra Lyon Ricardo L.F. Moreira Mariana C. Duarte Daniel Menezes-Souza Rachel B. Caligiorne Ricardo A. Machado-de-Ávila Eduardo A.F. Coelho 《Immunobiology》2019,224(4):477-484
The measures for leishmaniasis control include the precise diagnosis of disease. However, although several recombinant antigens have been tested with this biotechnological purpose, no effective product exists, which could detects patients with the active disease, as well as differentiates them from cured and treated patients. In this study, a conserved Leishmania hypothetical protein, which was identified in Leishmania infantum parasites, but evaluated to presents high homology in the amino acid sequences between distinct parasite species, was evaluated for the diagnosis of tegumentary and visceral leishmaniasis. In addition, PBMCs collected from treated and untreated mucosal leishmaniasis (ML) and visceral leishmaniasis (VL) patients, as well as in healthy subjects living in endemic region of disease, were in vitro stimulated, when IFN-γ, IL-4 and IL-10 levels were evaluated in the cell supernatant. Regarding the serological analyses, ELISA experiments using the recombinant protein (rLiHyL) and a human serological panel revealed high sensitivity and specificity values to detect both diseases, while control antigens showed worst results. Regarding the cellular response, results showed that rLiHyL-stimulated cells produced higher IFN-γ and lower IL-4 and IL-10 levels in the supernatants. Also, the anti-protein antibody production was evaluated in these patients, and data showed higher IgG2 and lower IgG1 levels found in the treated patients and healthy controls, demonstrating the stimulation of a Th1-type response induced by the rLiHyL protein. In conclusion, this hypothetical protein can be considered as antigenic in TL and VL, as well as a vaccine candidate to be tested in future studies to protect against disease. 相似文献
60.
Cristián Falcón-Beas Andrés Tittarelli Gabriela Mora-Bau Fabián Tempio Claudio Pérez Daniel Hevia Carolina Behrens Iván Flores Felipe Falcón-Beas Paola Garrido Gabriel Ascui Cristián Pereda Fermín E. González Flavio Salazar-Onfray Mercedes N. López 《Immunobiology》2019,224(5):697-705
BackgroundDendritic cells (DCs) are usually immunogenic, but they are also capable of inducing tolerance under anti-inflammatory conditions. Immunotherapy based on autologous DCs loaded with an allogeneic melanoma cell lysate (TRIMEL/DCs) induces immunological responses and increases melanoma patient survival. Glucocorticoids can suppress DC maturation and function, leading to a DC-mediated inhibition of T cell responses.MethodsThe effect of dexamethasone, a glucocorticoid extensively used in cancer therapies, on TRIMEL/DCs phenotype and immunogenicity was examined.ResultsDexamethasone induced a semi-mature phenotype on TRIMEL/DC with low maturation surface marker expressions, decreased pro-inflammatory cytokine induction (IL-1β and IL-12) and increased release of regulatory cytokines (IL-10 and TGF-β). Dexamethasone-treated TRIMEL/DCs inhibited allogeneic CD4+ T cell proliferation and cytokine release (IFNγ, TNF-α and IL-17). Co-culturing melanoma-specific memory tumor-infiltrating lymphocytes with dexamethasone-treated TRIMEL/DC inhibited proliferation and effector T cell activities, including cytokine secretion and anti-melanoma cytotoxicity.ConclusionsThese findings suggest that dexamethasone repressed melanoma cell lysate-mediated DC maturation, generating a potent tolerogenic-like DC phenotype that inhibited melanoma-specific effector T cell activities. These results suggest that dexamethasone-induced immunosuppression may interfere with the clinical efficacy of DC-based melanoma vaccines, and must be taken into account for optimal design of cellular therapy against cancer. 相似文献